NADSYN1 and head and neck cancer: Esophageal and head and neck cancers show the most striking NADSYN1 amplification frequency, (i.e., 19.23% and 13.77% of these tumors have amplified NADSYN1 gene expressions, respectively), implying that the PH pathway is heavily implicated in the pathophysiology of these two malignancies (Figure 3).